P. Maiolino

发表

Micrornas in prostate cancer: an overview

Gerardo Botti, Michele Caraglia, G. Botti, 2017, Oncotarget.

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study.

G. Botti, N. Normanno, G. de Feo, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1

G. Botti, M. Monaco, C. D'Alterio, 2019, Journal of Experimental & Clinical Cancer Research.

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology

G. Botti, P. Ascierto, S. Pignata, 2019, PloS one.

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting

G. Botti, G. Ciliberto, F. Buonaguro, 2017, Oncotarget.

Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective Analysis

F. Izzo, P. Delrio, A. Avallone, 2022, Journal of clinical medicine.

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

G. Botti, G. de Feo, F. Caponigro, 2016, BMC Cancer.

CpG‐ODN increases the release of VEGF in a mouse model of lung carcinoma

I. Adcock, C. Arra, P. Maiolino, 2011, International journal of cancer.

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice

G. Ciliberto, F. Buonaguro, L. Buonaguro, 2016, Journal of Translational Medicine.

Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma

I. Adcock, A. Luciano, C. Arra, 2012, The Journal of Immunology.

Mediate the Antitumor Activity of Cl-IB-MECA in a Mouse

I. Adcock, A. Luciano, C. Arra, 2011 .

NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model.

I. Adcock, A. Luciano, C. Arra, 2011, Neoplasia.

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Michael F. Sharpnack, D. Schadendorf, R. Sullivan, 2018, Journal of Translational Medicine.

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.

S. Scala, F. Tatangelo, P. Maiolino, 2015, International journal of surgery.

Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.

G. Ciliberto, C. Coppola, A. Barbieri, 2016, In vivo.

Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”

G. Ciliberto, S. Pignata, A. Crispo, 2016, Front. Pharmacol..

Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol

F. Izzo, P. Delrio, G. Botti, 2020, Therapeutic advances in medical oncology.

24 Nivolumab serum concentration in metastatic melanoma patients could be related to anti-tumor activity gene and outcome

G. Madonna, D. Mallardo, P. Ascierto, 2021, Journal for ImmunoTherapy of Cancer.

B cell depletion increases sphingosine-1-phosphate-dependent airway inflammation in mice.

P. Maiolino, G. Cirino, R. Sorrentino, 2015, American journal of respiratory cell and molecular biology.

Tolerance to the repolarization effects of rac-sotalol during long-term treatment.

P. Maiolino, G. Magnolfi, M. Ferrari, 2003, British journal of clinical pharmacology.

Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

D. Mallardo, P. Ascierto, E. Simeone, 2022, Journal of Translational Medicine.

Inhibition of Intestinal Motility and Secretion by Flavonoids in Mice and Rats: Structure‐activity Relationships

A. Izzo, P. Maiolino, N. Mascolo, 1993, The Journal of pharmacy and pharmacology.

Mouse Model of Melanoma Cell-Mediated Anti-tumor Immunity in a Inhibition of CD73 Improves B

A. Luciano, P. Maiolino, C. Cicala, 2012 .

G. Botti, N. Normanno, C. Pacilio, 2022 .

Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review

F. Caponigro, F. Ionna, P. Maiolino, 2022, Cancers.

From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples

S. Pignata, A. Crispo, M. Montella, 2016, Front. Pharmacol..

Validation of an LC-MS/MS method for simultaneous determination of icotinib and its four major circulating metabolites in human plasma and its application in a pharmacokinetic study.

P. Maiolino, Ying Xiao, Li Chen, 2018, Biomedical chromatography : BMC.

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer

P. Delrio, G. Botti, L. Portella, 2020, Cancers.

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

N. Normanno, A. Barbieri, L. Portella, 2022, Journal for ImmunoTherapy of Cancer.

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

S. Scala, A. Avallone, G. Nasti, 2016, Oncology.

Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model.

P. Maiolino, L. Miele, R. Iannone, 2014, American journal of cancer research.

Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model

F. Izzo, G. Ciliberto, F. Buonaguro, 2015, Cancer Immunology, Immunotherapy.

Plasmacytoid Dendritic Cells Alter the Antitumor Activity of CpG-Oligodeoxynucleotides in a Mouse Model of Lung Carcinoma

I. Adcock, A. Luciano, C. Arra, 2010, The Journal of Immunology.

Model of Lung Carcinoma CpG-Oligodeoxynucleotides in a Mouse Antitumor Activity of Plasmacytoid Dendritic Cells Alter the

A. Luciano, C. Arra, P. Maiolino, 2010 .

B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma.

I. Adcock, G. Palma, A. Luciano, 2011, American journal of respiratory and critical care medicine.

Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review

G. Botti, G. Ciliberto, M. Caraglia, 2016, Oncotarget.

Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences

G. Botti, G. Ciliberto, M. Caraglia, 2017, Oncotarget.

Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.

P. Maiolino, L. Miele, R. Iannone, 2013, Neoplasia.

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice

G. Ciliberto, F. Buonaguro, L. Buonaguro, 2016, Journal of Translational Medicine.

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition

S. Scala, G. Nasti, P. Maiolino, 2013, Front. Immun..

Corrigendum: Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”

G. Ciliberto, S. Pignata, A. Crispo, 2016, Front. Pharmacol..

Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

R. Piscitelli, P. Maiolino, C. von Arx, 2021, Pharmaceutics.

Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples

G. Botti, A. Avallone, P. Maiolino, 2018, Front. Public Health.

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

G. Botti, F. Caponigro, S. Scala, 2016, BMC Cancer.

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)

P. Delrio, G. Botti, E. Di Gennaro, 2014, BMC Cancer.

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian “Real-World” SAX Study

G. Ciliberto, S. Pignata, V. Conteduca, 2016, Front. Pharmacol..

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)

Antonella Petrillo, Vincenza Granata, Gerardo Botti, 2016, BMC Cancer.

Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis

D. Mallardo, P. Ascierto, S. Warren, 2022, Journal for immunotherapy of cancer.

Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by Electrochemotherapy

P. Delrio, G. Botti, A. Avallone, 2021, Cancers.

Post-exposure prophylaxis with sotrovimab for Omicron (B.1.1.529) SARS-CoV-2 variant during the aplastic phase of autologous stem cell transplantation

P. Maiolino, N. Coppola, A. Pinto, 2022, Infectious agents and cancer.

The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).

M. Caraglia, F. Fiore, D. Santini, 2007, Journal of experimental & clinical cancer research : CR.

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Michael F. Sharpnack, D. Schadendorf, R. Sullivan, 2018, Journal of Translational Medicine.

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study.

G. Botti, N. Normanno, G. Esposito, 2012 .

Induction of Inflammation Disrupts the Negative Interplay between STING and S1P Axis That Is Observed during Physiological Conditions in the Lung

A. Falanga, P. Maiolino, R. Sorrentino, 2023, International journal of molecular sciences.

Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker.

P. Delrio, P. Marchetti, C. Jemos, 2019, Toxicology letters.

Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization

D. Mallardo, P. Ascierto, E. Simeone, 2022, Journal of Translational Medicine.

Electrochemotherapy as palliative treatment in patients with recurrent and/or metastatic head and neck tumours: features analysis for an early determination of the partial responsive patients.

R. Fusco, P. Maiolino, L. Vaira, 2022, European review for medical and pharmacological sciences.

Clinical trials and drug cost savings for Italian health service

G. Botti, S. Pignata, P. Maiolino, 2020, BMC Health Services Research.

Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice

V. Granata, G. Nasti, O. Gualillo, 2024, Cancers.

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

S. Scala, A. Avallone, G. Nasti, 2016, Oncology.

Corrigendum: Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”

G. Ciliberto, S. Pignata, A. Crispo, 2016, Front. Pharmacol..

Pazopanib in Metastatic Renal Cancer: A “Real-World” Experience at National Cancer Institute “Fondazione G. Pascale”

G. Ciliberto, S. Pignata, A. Crispo, 2016, Front. Pharmacol..